Gastrointestinal Lipase Inhibitor
Semantic Scholar uses AI to extract papers important to this topic.
- British journal of clinical pharmacology
To assess the efficacy, pharmacodynamics, safety and tolerability of a range of doses of cetilistat, a novel inhibitor of… (More)
The purpose of this study was to examine the possible effects of a gastrointestinal lipase inhibitor "Orlistat (Xenical… (More)
Orlistat is an oral inhibitor of gastrointestinal lipase used for weight reduction in obese patients. Although most adverse drug… (More)
Unabsorbed fat and bile acids may react with calcium in the intestinal lumen, limiting the amount of free calcium… (More)
- Archives of family medicine
To evaluate the long-term efficacy and tolerability within primary care settings of orlistat, a gastrointestinal lipase… (More)
- The American journal of clinical nutrition
Long-term maintenance of weight loss remains a therapeutic challenge in obesity treatment.
Orlistat, a gastrointestinal lipase inhibitor that reduces dietary fat absorption by approximately 30%, may promote… (More)
Orlistat, a gastrointestinal lipase inhibitor, decreases fat absorption and thus it reduces caloric intake. The objectives of… (More)
We undertook a randomised controlled trial to assess the efficacy and tolerability of orlistat, a gastrointestinal… (More)
- European Journal of Clinical Pharmacology
The effect of orlistat, a nonabsorbed inhibitor of gastric and pancreatic lipases, was examined in patients with primary… (More)